Kailera Therapeutics, Inc. insider trading
KLRA$10.39-0.64 (-5.80%)
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Apr 17, 2026 to Oct 2, 2026. Price (-60.0%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Open market purchase
Open market sellNet dollar flow · Buy / Sell balance
PremiumQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Unlock quarterly net flowKey players
- ATAndrew T. Kaplan20.2521%
- AKAdam Koppel17.4195%
- JHJiangsu Hengrui Pharmaceuticals Co., Ltd.1.569%
- RCRonald C. Renaud Jr.0.0294%
- RIRTW Investments, LPNot reported
- BFBCLS Fund IV Investments GP, LLCNot reported
- BPBCPE Perseus Investor, LPNot reported
AI Activity Analysis
PremiumComing soon
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| KLRA | RTW Investments, LP | Open market purchase$8M | +4.9% | $16.00 | $8M | Apr 20, 2026 | Apr 22, 2026 |
| KLRA | BCPE Perseus Investor, LP | Open market purchase$134M | +47.0% | $16.00 | $134M | Apr 20, 2026 | Apr 20, 2026 |
| KLRA | Adam Koppel | Open market purchase$25M | +7.4% | $16.00 | $25M | Apr 20, 2026 | Apr 20, 2026 |
| KLRA | BCLS Fund IV Investments GP, LLC | Open market purchase$25M | +7.4% | $16.00 | $25M | Apr 20, 2026 | Apr 20, 2026 |
| KLRA | Andrew T. Kaplan | Open market purchase$134M | +47.0% | $16.00 | $134M | Apr 20, 2026 | Apr 20, 2026 |